These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27726357)

  • 1. Active Site Mapping of an Aspartic Protease by Multiple Fragment Crystal Structures: Versatile Warheads To Address a Catalytic Dyad.
    Radeva N; Schiebel J; Wang X; Krimmer SG; Fu K; Stieler M; Ehrmann FR; Metz A; Rickmeyer T; Betz M; Winquist J; Park AY; Huschmann FU; Weiss MS; Mueller U; Heine A; Klebe G
    J Med Chem; 2016 Nov; 59(21):9743-9759. PubMed ID: 27726357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Active-Site Mapping by Fragments: Hot Spots Remote from the Catalytic Center of Endothiapepsin.
    Radeva N; Krimmer SG; Stieler M; Fu K; Wang X; Ehrmann FR; Metz A; Huschmann FU; Weiss MS; Mueller U; Schiebel J; Heine A; Klebe G
    J Med Chem; 2016 Aug; 59(16):7561-75. PubMed ID: 27463859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the orientation of the catalytic dyad in aspartic proteases.
    Friedman R; Caflisch A
    Proteins; 2010 May; 78(6):1575-82. PubMed ID: 20112416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the active site protonation state in aspartic proteases: implications for drug design.
    Sussman F; Villaverde MC; Domínguez JL; Danielson UH
    Curr Pharm Des; 2013; 19(23):4257-75. PubMed ID: 23170891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes.
    Köster H; Craan T; Brass S; Herhaus C; Zentgraf M; Neumann L; Heine A; Klebe G
    J Med Chem; 2011 Nov; 54(22):7784-96. PubMed ID: 21972967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking.
    Metz A; Wollenhaupt J; Glöckner S; Messini N; Huber S; Barthel T; Merabet A; Gerber HD; Heine A; Klebe G; Weiss MS
    Acta Crystallogr D Struct Biol; 2021 Sep; 77(Pt 9):1168-1182. PubMed ID: 34473087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of endothiapepsin-fragment complexes from crystallographic fragment screening using a novel, diverse and affordable 96-compound fragment library.
    Huschmann FU; Linnik J; Sparta K; Ühlein M; Wang X; Metz A; Schiebel J; Heine A; Klebe G; Weiss MS; Mueller U
    Acta Crystallogr F Struct Biol Commun; 2016 May; 72(Pt 5):346-55. PubMed ID: 27139825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
    J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study.
    Schiebel J; Radeva N; Krimmer SG; Wang X; Stieler M; Ehrmann FR; Fu K; Metz A; Huschmann FU; Weiss MS; Mueller U; Heine A; Klebe G
    ACS Chem Biol; 2016 Jun; 11(6):1693-701. PubMed ID: 27028906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket.
    Huang CY; Metz A; Lange R; Artico N; Potot C; Hazemann J; Müller M; Dos Santos M; Chambovey A; Ritz D; Eris D; Meyer S; Bourquin G; Sharpe M; Mac Sweeney A
    Acta Crystallogr D Struct Biol; 2024 Feb; 80(Pt 2):123-136. PubMed ID: 38289714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomic resolution crystal structure of Sapp2p, a secreted aspartic protease from Candida parapsilosis.
    Dostál J; Pecina A; Hrušková-Heidingsfeldová O; Marečková L; Pichová I; Řezáčová P; Lepšík M; Brynda J
    Acta Crystallogr D Biol Crystallogr; 2015 Dec; 71(Pt 12):2494-504. PubMed ID: 26627656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and computational active site mapping as a starting point to fragment-based lead discovery.
    Behnen J; Köster H; Neudert G; Craan T; Heine A; Klebe G
    ChemMedChem; 2012 Feb; 7(2):248-61. PubMed ID: 22213702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Nothing Boosts Affinity: Hydrophobic Ligand Binding to the Virtually Vacated S
    Krimmer SG; Cramer J; Schiebel J; Heine A; Klebe G
    J Am Chem Soc; 2017 Aug; 139(30):10419-10431. PubMed ID: 28696673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of subdomain orientation, conformational change and disorder in relation to crystal packing of aspartic proteinases.
    Bailey D; Carpenter EP; Coker A; Coker S; Read J; Jones AT; Erskine P; Aguilar CF; Badasso M; Toldo L; Rippmann F; Sanz-Aparicio J; Albert A; Blundell TL; Roberts NB; Wood SP; Cooper JB
    Acta Crystallogr D Biol Crystallogr; 2012 May; 68(Pt 5):541-52. PubMed ID: 22525752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of a bi-functional Kunitz-type STI family inhibitor of serine and aspartic proteases: Could the aspartic protease inhibition have evolved from a canonical serine protease-binding loop?
    Guerra Y; Valiente PA; Pons T; Berry C; Rudiño-Piñera E
    J Struct Biol; 2016 Aug; 195(2):259-271. PubMed ID: 27329566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
    Tochowicz A; Maskos K; Huber R; Oltenfreiter R; Dive V; Yiotakis A; Zanda M; Pourmotabbed T; Bode W; Goettig P
    J Mol Biol; 2007 Aug; 371(4):989-1006. PubMed ID: 17599356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
    Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
    J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
    J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-64c-hydrazide: a lead structure for the development of irreversible cathepsin C inhibitors.
    Radzey H; Rethmeier M; Klimpel D; Grundhuber M; Sommerhoff CP; Schaschke N
    ChemMedChem; 2013 Aug; 8(8):1314-21. PubMed ID: 23780739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach.
    Konstantinidou M; Magari F; Sutanto F; Haupenthal J; Jumde VR; Ünver MY; Heine A; Camacho CJ; Hirsch AKH; Klebe G; Dömling A
    ChemMedChem; 2020 Apr; 15(8):680-684. PubMed ID: 32187447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.